PI Pharma Insight

BNF presentation directory

Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.

Reset
Presentation Product Chemical substance Chapter Items dispensed
Ketoprofen 10% gel
100302010AAACAC
Ketoprofen (Topical) Ketoprofen Musculoskeletal and Joint Diseases No data available
Ketoprofen 100mg / Omeprazole 20mg modified-release capsules
1001010L0AAAMAM
Ketoprofen (Systemic) Ketoprofen Musculoskeletal and Joint Diseases No data available
Ketoprofen 100mg capsules
1001010L0AAABAB
Ketoprofen (Systemic) Ketoprofen Musculoskeletal and Joint Diseases No data available
Ketoprofen 100mg/2ml solution for injection ampoules
1001010L0AAAGAG
Ketoprofen (Systemic) Ketoprofen Musculoskeletal and Joint Diseases No data available
Ketoprofen 150mg modified-release capsules
1001010L0AAALAL
Ketoprofen (Systemic) Ketoprofen Musculoskeletal and Joint Diseases No data available
Ketoprofen 200mg / Omeprazole 20mg modified-release capsules
1001010L0AAANAN
Ketoprofen (Systemic) Ketoprofen Musculoskeletal and Joint Diseases No data available
Ketoprofen 50mg capsules
1001010L0AAAAAA
Ketoprofen (Systemic) Ketoprofen Musculoskeletal and Joint Diseases No data available
Ketotard XL 200mg capsules
1001010L0BLAAAJ
Ketotard Ketoprofen Musculoskeletal and Joint Diseases No data available
Ketovail 100mg modified-release capsules
1001010L0BEAAAI
Ketovail Ketoprofen Musculoskeletal and Joint Diseases No data available
Ketovail 200mg modified-release capsules
1001010L0BEABAJ
Ketovail Ketoprofen Musculoskeletal and Joint Diseases No data available
Ketozip 200 XL capsules
1001010L0BKAAAJ
Ketozip Ketoprofen Musculoskeletal and Joint Diseases No data available
Ketpron XL 100mg capsules
1001010L0BPAAAI
Ketpron Ketoprofen Musculoskeletal and Joint Diseases No data available
Ketpron XL 200mg capsules
1001010L0BPABAJ
Ketpron Ketoprofen Musculoskeletal and Joint Diseases No data available
Kevzara 150mg/1.14ml inj pre-filled syringes
1001030ADBBAAAA
Kevzara Sarilumab Musculoskeletal and Joint Diseases No data available
Kevzara 150mg/1.14ml solution for injection pre-filled pens
1001030ADBBACAC
Kevzara Sarilumab Musculoskeletal and Joint Diseases No data available
Kevzara 200mg/1.14ml inj pre-filled syringes
1001030ADBBABAB
Kevzara Sarilumab Musculoskeletal and Joint Diseases No data available
Kevzara 200mg/1.14ml solution for injection pre-filled pens
1001030ADBBADAD
Kevzara Sarilumab Musculoskeletal and Joint Diseases No data available
Kineret 100mg/0.67ml inj pre-filled syringes
1001030R0BBAAAA
Kineret Anakinra Musculoskeletal and Joint Diseases No data available
Lamberts Vegan Glucosamine hydrochloride 660mg tablets
1001050A0CBABAR
Lambert's (Glucosamine hydrochloride) Glucosamine hydrochloride (Rheumatic) Musculoskeletal and Joint Diseases No data available
Lamberts Vegetarian Glucosamine hydrochloride 750mg tablets
1001050A0CBAAAB
Lambert's (Glucosamine hydrochloride) Glucosamine hydrochloride (Rheumatic) Musculoskeletal and Joint Diseases No data available
Lederfen 300mg capsules
1001010F0BBAAAA
Lederfen Fenbufen Musculoskeletal and Joint Diseases No data available
Lederfen 300mg tablets
1001010F0BBABAB
Lederfen Fenbufen Musculoskeletal and Joint Diseases No data available
Lederfen 450mg tablets
1001010F0BBADAC
Lederfen Fenbufen Musculoskeletal and Joint Diseases No data available
Lederspan 100mg/5ml suspension for injection vials
1001022Y0BBACAC
Lederspan Triamcinolone hexacetonide Musculoskeletal and Joint Diseases No data available
Lederspan 20mg/1ml suspension for injection vials
1001022Y0BBABAB
Lederspan Triamcinolone hexacetonide Musculoskeletal and Joint Diseases No data available

Why monitor BNF codes?

Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.

Track cost pressure

Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.

Understand demand drivers

Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.